EDITAS MEDICINE, INC. Public Float
EDITAS MEDICINE, INC. (EDIT) had Public Float of $191.38 million as of 2025-06-30, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-09
- 2025-06-30: Entity Public Float $191.38M.
- 2024-06-28: Entity Public Float $383.85M.
- 2023-06-30: Entity Public Float $671.13M.
- 2022-06-30: Entity Public Float $633.81M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $191.38M 10-K · filed 2026-03-09 |
| 2024-06-28 | $383.85M 10-K · filed 2025-03-05 |
| 2023-06-30 | $671.13M 10-K · filed 2024-02-28 |
| 2022-06-30 | $633.81M 10-K · filed 2023-02-22 |
| 2021-06-30 | $1.15B 10-K · filed 2022-02-24 |
| 2020-06-30 | $1.84B 10-K · filed 2021-02-26 |
| 2019-06-28 | $1.22B 10-K · filed 2020-02-26 |
| 2018-06-30 | $1.63B 10-K · filed 2019-03-01 |
| 2017-06-30 | $502.96M 10-K · filed 2018-03-08 |
| 2016-06-30 | $442.57M 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |